Truist Securities Downgrades Harmony Biosciences Holdings, Inc. (HRMY) to Hold After Patent Trial Developments

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is 1 of the best concern stocks connected our list.

TheFly reported connected February 20 that Truist Securities downgraded HRMY from Buy to Hold pursuing the decision of its seat proceedings against Paragraph IV filer AET Pharma. The expert pointed retired that Judge Hall's aboriginal post-trial comments raised the anticipation of Harmony's lawsuit ending badly. The company consequently voiced concerns implicit the Wakix franchise, pointing retired that there was a precocious risk and a bully accidental that generic rivals would articulation the marketplace earlier 2029.

On February 17, Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) announced that the U.S. Food and Drug Administration (FDA) had approved its supplemental New Drug Application for WAKIX (pitolisant) tablets to dainty cataplexy successful children with narcolepsy who are six years of property oregon older. Regardless of whether a kid has cataplexy oregon not, Wakix is present the archetypal and lone FDA-approved non-scheduled therapy for narcolepsy. This accomplishment expands the scope of therapy options disposable to patients of each ages by enabling physicians to prescribe WAKIX to patients six years of property and older for excessive daytime sleepiness, cataplexy, oregon both.

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is simply a biopharmaceutical institution processing therapies for uncommon neurological disorders, focusing connected innovative treatments for conditions similar narcolepsy and different sleep-related diseases.

While we admit the imaginable of HRMY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 Unstoppable Dividend Stocks to Buy According to Analysts and Dividend Champions, Contenders and Challengers list: 15 Highest Yielding Stocks.

Disclosure: None. Follow Insider Monkey connected Google News.